Oura, a leader in the smart ring market, has announced its acquisition of AI-native primary care startup Counsel Health for $625 million. This strategic move comes just weeks after Oura postponed its anticipated IPO, which was projected to reach up to $2.2 billion, citing uncertainty in the current IPO market. The acquisition is seen as a pivotal step for Oura to innovate and expand its services in the face of growing competition from emerging rivals like RingConn and Ultrahuman.
Oura's Strategic Expansion into Healthcare
Counsel Health, known for its AI-powered healthcare platform, offers a chat-based medical experience that connects users with licensed physicians. This service was integrated into the Oura app back in June, allowing users to receive personalized medical advice and consult with healthcare professionals directly through the app. The acquisition aims to build upon this existing partnership, focusing on preventative care, acute care, and specialty and chronic care.
Oura CEO Tom Hale emphasized the importance of this acquisition, stating, "Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals." This integration of AI-driven healthcare services positions Oura to not only enhance user engagement but also to provide comprehensive health solutions.
Financial Metrics and Growth Trajectory
The financial implications of this acquisition are significant. Oura reported a remarkable 153% year-over-year revenue growth, reaching $533 million for the quarter ending September 30, 2026. For the fiscal year 2026, Oura generated approximately $1.75 billion in revenue, marking a 92% increase compared to the previous year. This growth trajectory has contributed to Oura's valuation soaring to $11 billion following a $900 million late-stage funding round in October 2025.
The acquisition of Counsel Health, which raised $25 million in a Series A funding round led by Andreessen Horowitz and GV, adds to Oura's robust financial standing. Counsel Health had raised a total of $36 million, and its integration into Oura is expected to enhance the overall value proposition for both companies.
Leadership Transition and Future Plans
As part of the acquisition, Counsel CEO Muthu Alagappan will join Oura as the Chief Clinical AI Officer, bringing along his team of 70 employees. Alagappan expressed enthusiasm about the merger, stating, "At Counsel, we’ve built medical AI around trust, safety, and responsibility, keeping physicians in the loop for clinical decisions. Oura’s data gives clinicians objective context, trended biometrics, and member engagement to deliver more informed care."
This leadership transition signifies a commitment to maintaining the integrity of Counsel Health's AI-driven model while leveraging Oura's extensive user base and technological capabilities. The companies aim to expand their AI-native care model beyond Oura’s membership, reaching a broader audience and enhancing healthcare accessibility.
Market Context and Competitive Landscape
Oura's acquisition of Counsel Health comes at a time when the company faces increasing pressure from competitors in the smart health technology sector. Rivals like RingConn and Ultrahuman are emerging with innovative solutions, prompting Oura to continuously evolve its offerings. By integrating Counsel Health's AI capabilities, Oura not only strengthens its position in the market but also addresses the growing demand for accessible healthcare solutions.
The deal is expected to close before the end of 2027, and both companies are optimistic about the future of their partnership. The integration of AI into healthcare is a growing trend, and Oura's proactive approach positions it as a leader in this space.
Conclusion: A New Era for Oura and Counsel Health
The acquisition of Counsel Health marks a significant milestone for Oura as it navigates the complexities of the healthcare landscape. By combining advanced AI technology with a robust healthcare platform, Oura is set to redefine how users interact with their health and wellness. As the healthcare industry continues to evolve, Oura's strategic moves will be closely watched by investors and consumers alike, signaling a new era in AI-driven healthcare solutions.
| Forensic Metric / Statutory Dimension | Mainstream Wire Benchmark | DotMR Corroborated Record & Direct Impact |
|---|---|---|
| Acquisition Value | $625 million | Oura acquires Counsel Health for $625M |
| Revenue Growth (Q3 2026) | 153% year-over-year | Oura reports $533 million revenue |
| Total Revenue (FY 2026) | $1.75 billion | Oura's revenue marks 92% growth |
| Counsel Health Total Funding | $36 million | Counsel raised $25M Series A |
| Valuation Post-Funding | $11 billion | Oura's valuation after $900M funding |
